Company chart and information is provided by TradingView based on 15-minute-delayed data.
Evelo Biosciences Inc is a United States-based biotechnology company. It is engaged in discovering and developing a new class of orally delivered investigational medicines that are intended to act on cells in the small intestine to produce therapeutic effects throughout the body. Its lead product candidate under development is EDP1815, which is for the treatment of inflammatory diseases and the hyperinflammatory response associated with COVID-19. Other products in the pipeline include EDP1867 and EDP2939 for the treatment of inflammatory disease and EDP1908 for the treatment of cancer.
| Website: | www.evelobio.com |
| Email: | ir@evelobio.com |
| Main Phone: | +1 617 577-0300 |
| Address: | 620 Memorial Drive |
| Address 2: | 5th Floor |
| State: | MA |
| City / Town: | Cambridge |
| Country: | US |
| Postal Code: | 02139 |
| Exchange: | NGS |
| CEO: | Balkrishan Gill |
| Employees: | 90 |
| NAICS: | Medicinal and Botanical Manufacturing(325411) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
